Internal Medicine · Lancaster, CA
NPI
1699951830
Since 2008
Specialty
Internal Medicine
Code 207R00000X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
615 W Avenue L
Lancaster, CA, 93534
Phone (661) 723-2879
Groups this clinician bills Medicare through
Medicare paid, 2024
$1,803
23 services
Medicare patients, 2024
11
Average age 67
Drug cost, 2024
$462K
2,485 prescriptions
Company payments, 2023
$265
From 2 companies
Medicare prescription drug claims, 2024
In 2024, the drug Manish J Desai prescribed most often to Medicare patients was Levothyroxine Sodium, with 327 prescriptions and refills. In total Manish J Desai wrote 2,485 Medicare prescriptions that cost $462K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-12-06.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Levothyroxine Sodium Generic | 327 | 1,057 | 107 | $8,374 |
| Insulin Glargine-Yfgn Generic | 183 | 517 | 75 | $31K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 158 | 424 | 75 | $5,993 |
| Methimazole Generic | 139 | 456 | 53 | $2,740 |
| Humalog Kwikpen U-100 Insulin Lispro | 131 | 321 | 50 | $58K |
| Humalog Insulin Lispro | 121 | 366 | 42 | $36K |
| Jardiance Empagliflozin | 104 | 343 | 43 | $56K |
| Atorvastatin Calcium Generic | 87 | 288 | 33 | $1,040 |
| Losartan Potassium Generic | 86 | 287 | 29 | $1,007 |
| Ozempic Semaglutide | 83 | 89 | 16 | $63K |
| Humulin 70/30 Kwikpen Insulin Nph Hum/Reg Insulin Hm | 78 | 210 | 30 | $25K |
| Metformin Hcl Er Metformin Hcl | 70 | 230 | 30 | $592 |
| Lisinopril Generic | 55 | 183 | 24 | $632 |
| Hydrocortisone Generic | 50 | 158 | 18 | $2,930 |
| Veo Insulin Syringe Syringe-Needle,insulin,0.5 Ml | 44 | 136 | 18 | $1,679 |
Brand drugs: 948 claims; generic drugs: 1,181 claims.
Money and other things of value reported by the companies
In 2023, drug and medical device companies paid Manish J Desai $265 ($265 in general payments such as food, travel and fees) from 2 companies. The largest payer was Abbott Laboratories with $166.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.